Not applicableStudy completedNCT02497885What this trial is testingSeroprevalence of MERS-CoV IgG in Healthcare WorkersWho this might be right forCoronavirus Infections Ewha Womans University Mokdong Hospital 737
Testing effectiveness (Phase 2)UnknownNCT04412395What this trial is testingClinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 DiseaseWho this might be right forCorona Virus InfectionMiddle East Respiratory Syndrome (MERS)Acute Respiratory Distress Syndrome+3 more National Research Centre, Egypt 516
Early research (Phase 1)Study completedNCT02788188What this trial is testingSafety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy AdultsWho this might be right forMiddle East Respiratory Syndrome Coronavirus National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)WithdrawnNCT02190799What this trial is testingAnti-MERS-CoV Convalescent Plasma TherapyWho this might be right forRespiratory Distress Syndrome (& [Hyaline Membrane Disease]) King Abdullah International Medical Research Center
Testing effectiveness (Phase 2)UnknownNCT04128059What this trial is testingStudy of Safety and Immunogenicity of BVRS-GamVac-CombiWho this might be right forMERS (Middle East Respiratory Syndrome)MERS Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 268
Not applicableStudy completedNCT04415359What this trial is testingEvaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic PeriodWho this might be right forCovid-19 University Hospital, Strasbourg, France 700
Early research (Phase 1)Study completedNCT03615911What this trial is testingSafety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-SWho this might be right forMERS (Middle East Respiratory Syndrome) Marylyn Addo 26
Early research (Phase 1)Study completedNCT04170829What this trial is testingA Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)Who this might be right forMiddle East Respiratory Syndrome Coronavirus King Abdullah International Medical Research Center 24
Early research (Phase 1)Study completedNCT02670187What this trial is testingPhase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy VolunteersWho this might be right forHealthy GeneOne Life Science, Inc. 75
Not applicableStudy completedNCT02605109What this trial is testingAnalysis of Human to Human Transmission of Middle East Respiratory Syndrom Coronavirus (MER-CoV)Who this might be right forViral Infection Konkuk University Medical Center 200
Not applicableStudy completedNCT01056354What this trial is testingRespiratory Virus Outpatient Study (FLU 002 Plus)Who this might be right forInfluenza and Other Novel Respiratory Viruses University of Minnesota 11,719
Testing effectiveness (Phase 2)UnknownNCT04130594What this trial is testingStudy of Safety and Immunogenicity of BVRS-GamVacWho this might be right forMERS (Middle East Respiratory Syndrome)MERS Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 162
Early research (Phase 1)Study completedNCT04119440What this trial is testingSafety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERSWho this might be right forMERS (Middle East Respiratory Syndrome) Universitätsklinikum Hamburg-Eppendorf 145
Early research (Phase 1)Ended earlyNCT03399578What this trial is testingSafety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)Who this might be right forMERS (Middle East Respiratory Syndrome) University of Oxford 29
Testing effectiveness (Phase 2)Study completedNCT06857318What this trial is testingColostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.Who this might be right forCOVID 19 Hadassah Medical Organization 43
Not applicableStudy completedNCT01056185What this trial is testingRespiratory Virus Hospitalization Study (FLU 003 Plus)Who this might be right forInfluenzaNovel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) University of Minnesota 1,000
Early research (Phase 1)WithdrawnNCT05614245What this trial is testingSafety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 AdjuvantWho this might be right forCOVID-19Coronavirus Infections VBI Vaccines Inc.
Testing effectiveness (Phase 2)Study completedNCT03721718What this trial is testingEvaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy VolunteersWho this might be right forHealthy GeneOne Life Science, Inc. 60
Early research (Phase 1)Study completedNCT03301090What this trial is testingA Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051Who this might be right forCorona Virus Infection National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableUnknownNCT04672577What this trial is testingInfection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and MalariaWho this might be right forTravel-Related IllnessMalariaDengue+6 more Patricia Schlagenhauf 10,000